Monday, 16, March, 2026 / Published in Malaysia, News, Pharma & Biotech

Malaysia Introduces Reliance and Priority Review Mechanisms for Additional Drug Indication Applications

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has introduced new regulatory mechanisms intended to streamline the review of additional indication applications…

Tuesday, 10, March, 2026 / Published in Malaysia, News, Pharma & Biotech

Malaysia Mandates Testing for Diethylene Glycol (DEG) and Ethylene Glycol (EG) in High-Risk Oral Liquid Products

On February 10, 2026, the National Pharmaceutical Regulatory Agency (NPRA), under the Ministry of Health Malaysia, issued “Directive No. 8…

Tuesday, 10, March, 2026 / Published in Malaysia, News, Pharma & Biotech

Malaysia Mandates GCP 5th Edition for Clinical Trials Under New NPRA Directive

On January 29, 2026, the National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health Malaysia issued “Directive No. 7…